The effect of the Russian combined vector vaccine against the novel coronavirus infection caused by SARS-CoV-2 on ovarian reserve and menstrual function in reproductive-aged women
- Authors: Dolgushina N.V.1, Dovgan A.A.1, Drapkina Y.S.1, Ivanets T.Y.1, Vtorushina V.V.1, Gus A.I.1, Sukhikh G.T.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Issue: No 4 (2022)
- Pages: 115-122
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/274413
- DOI: https://doi.org/10.18565/aig.2022.4.115-122
- ID: 274413
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Nataliya V. Dolgushina
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: _dolgushina@oparina4.ru
MD, PhD, Professor, Deputy Director - Chief of the Department for Scientific Projects Organization
Alina A. Dovgan
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: lina.dovgan@gmail.com
MD, Postgraduate Student, Prof. BV. Leonov Department of Assistive Technologies in Infertility Treatment
Yuliya S. Drapkina
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: yu_drapkina@oparina4.ru
MD, PhD, Prof. BV. Leonov Department of Assistive Technologies in Infertility Treatment
Tatyana Yu. Ivanets
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: t_ivanets@oparina4.ru
MD, PhD, Head of the Clinical Diagnostic Laboratory
Valentina V. Vtorushina
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: vtorushina@inbox.ru
PhD, Doctor of Clinical Laboratory Diagnostics
Alexander I. Gus
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of RussiaMD, PhD, Professor, Chief Researcher at the Department of Ultrasound and Functional Diagnostics
Gennady T. Sukhikh
Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: g_sukhikh@oparina4.ru
Dr. Med. Sci., Professor, Academician of the RAS, Director
References
- Logunov D.Y., Dolzhikova I., Shcheblyakov D., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021; 397(10275): 671-81. https://dx.doi.org/10.1016/S0140-6736(21)00234-8.
- Orvieto R., Noach-Hirsh M., Segev-Zahav A., Haas J., Nahum R., Aizer A. Does mRNA SARS-CoV-2 vaccine influence patients’ performance during IVF-ET cycle? Reprod. Biol. Endocrinol. 2021; 19(1): 69. https://dx.doi.org/10.1186/s12958-021-00757-6.
- Bentov Y., Beharier O., Moav-Zafrir A., Kabessa M., Godin M., Greenfield C.S. et al. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Hum. Reprod. 2021; 36(9): 2506 13. https://dx.doi.org/10.1093/humrep/deab182
- Lifshitz D., Haas J., Lebovitz O., Raviv G., Orvieto R., Aizer A. Does mRNA SARS-CoV-2 vaccine detrimentally affect male fertility, as reflected by semen analysis? Reprod. Biomed. Online. 2022; 44(1): 145-9. https://dx.doi.org/10.1016/j.rbmo.2021.09.021.
- Gonzalez D.C., Nassau D.E., Khodamoradi K., Ibrahim E., Blachman-Braun R., Ory J. et al. Sperm Parameters Before and After COVID-19 mRNA Vaccination. JAMA. 2021; 326(3): 273-4. https://dx.doi.org/10.1001/jama.2021.9976.
- Mohr-Sasson A., Haas J., Abuhasira S., Sivan M., Doitch Amdurski H., Dadon T. et al. The effect of Covid-19 mRNA vaccine on serum anti-Mullerian hormone levels. Hum. Reprod. 2022; 37(3): 534-41. https://dx.doi.org/10.1093/humrep/deab282.
- Драпкина Ю.С., Долгушина Н.В., Шатылко Т.В., Николаева М.А., Менжинская И.В., Иванец Т.Ю., Кречетова Л.В., Красный А.М., Гамидов С.И., Байрамова ГР, Сухих Г.Т. Вакцина Гам-КОВИД-Вак (Спутник V) не оказывает негативного влияния на сперматогенез у мужчин. Акушерство и гинекология. 2021; 7: 88-94. [Drapkina Yu.S., Dolgushina N.V., Shatylko T.V., Nikolaeva M.A., Menzhinskaya I.V., Ivanets T.Yu., Krechetova L.V., Krasnyi A.M., Gamidov S.I., Bairamova G.R., Sukhikh G.T. Gam-COVID-Vac (Sputnik V) vaccine has no adverse effect on spermatogenesis in men. Akusherstvo i Ginekologiya/ Obstetrics and Gynecology. 2021; 7: 88-94 (in Russian)]. https://dx.doi.org/10.18565/aig.202L7.88-94.
- Долгушина Н.В., Драпкина Ю.С., Кречетова Л.В., Иванец Т.Ю., Менжинская И.В., Гус А.И., Байрамова Г.Р., Сухих Г.Т. Вакцина Гам-КОВИД-Вак (Спутник V) не оказывает негативного влияния на овариальный резерв у женщин репродуктивного возраста. Акушерство и гинекология. 2021; 7: 81-6. https://dx.doi.org/10.18565/aig.2021.7.81-86.
- Guimaraes L.E., Baker B., Perricone C., Shoenfeld Y. Vaccines, adjuvants and autoimmunity. Pharmacol. Res. 2015; 100(January): 190-209. https://dx.doi.org/10.1016/j.phrs.2015.08.003.
- Shoenfeld Y., Agmon-Levin N. “ASIA” - autoimmune/inflammatory syndrome induced by adjuvants. J. Autoimmun. 2011; 36(1): 4-8. https://dx.doi.org/10.1016/j.jaut.2010.07.003.
- Watad A., Bragazzi N.L., McGonagle D., Adawi M., Bridgewood C., Damiani G. et al. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: Insights from an analysis of 500 cases. Clin. Immunol. 2019; 203(March): 1-8. https://dx.doi.org/10.1016/j.clim.2019.03.007.
- Carp H.J.A., Selmi C., Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J. Autoimmun. 2012; 38(2-3): J266-74. https://dx.doi.org/10.1016/j.jaut.2011.11.016.
- Cruz-Tapias P., Blank M., Anaya J.M., Shoenfeld Y. Infections and vaccines in the etiology of antiphospholipid syndrome. Curr. Opin. Rheumatol. 2012; 24(4): 389-93. https://dx.doi.org/10.1097/BOR.0b013e32835448b8.
- Zivkovic I., Stojanovic M., Petrusic V., Inic-Kanada A., Dimitrijevic L. Induction of APS after TTd hyper-mmunization has a Different Outcome in BALB/c and C57BL/6 Mice. Am. J. Reprod. Immunol. 2011; 65(5): 492-502. https://dx.doi.org/10.1111/j.1600-0897.2010.00922.x.
- Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020; 46(4): 586-90. https://dx.doi.org/10.1007/s00134-020-05985-9.
- Vaz-Silva J., Carneiro M.M., Ferreira M.C., Pinheiro S.V.B., Silva D.A., Silva A.L. et al. The vasoactive peptide angiotensin-(1-7), its receptor mas and the angiotensin-converting enzyme type 2 are expressed in the human endometrium. Reprod. Sci. 2009; 16(3): 247-56. https://dx.doi.org/10.1177/1933719108327593.
- Valdes G., Neves L.A.A., Anton L., Corthorn J., Chacon C., Germain A.M. et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta. 2006; 27(2-3): 200-7. https://dx.doi.org/10.1016/j.placenta.2005.02.015.
- Ding T., Wang T., Zhang J., Cui P., Chen Z., Zhou S. et al. Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: An observational study. Front. Med. 2021; 8: 635255. https://dx.doi.org/10.3389/fmed.2021.635255.
- Долгушин Г.О., Романов А.Ю. Влияние SARS-CoV-2 на репродукцию человека. Акушерство и гинекология. 2020; 11: 6-12. [Dolgushin G.O., Romanov A.Yu. Impact of SARS-CoV-2 on human reproduction. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2020; 11: 6-12 (in Russian)]. https://dx.doi.org/10.18565/aig.2020.11.6-12.
Supplementary files
![](/img/style/loading.gif)